Disease

Preeclampsia

3 developments in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

Latest

Everything in the corpus, newest first.

AUG 17, 2026 · PHASE 4 TRIAL

Progesterone Preeclampsia

ClinicalTrials.gov

This is a registered, actively recruiting Phase 4 RCT with no published results; the study design is sound but no efficacy data are yet available to assess.

PreliminaryNCT07448597 Medical University of South Carolina Progesterone supplementation

Reported

Planned enrollment642

Study phasePhase 4

Primary outcome measureDevelopment of preeclampsia, antenatally an…

AUG 12, 2026 · INTERVENTIONAL STUDY

The PreEclampsia Postpartum Prevention Trial

ClinicalTrials.gov

This is a clinical trial registry record describing a planned interventional study with no results reported; enrollment is ongoing and primary outcomes have not yet been assessed.

PreliminaryNCT07199283 Postpartum Period Bundle Intervention

Reported

Estimated enrollment356

Primary outcome measure 1Change in systolic blood pressure (mmHg) fr…

Primary outcome measure 2Change in diastolic blood pressure (mmHg) f…

AUG 6, 2026 · PHASE 3 TRIAL

Cardiovascular Protection After Preeclampsia With Enalapril

ClinicalTrials.gov

This is an active clinical trial registration with no reported results; the study is still recruiting and measures feasibility and retention rather than clinical efficacy.

PreliminaryStandard treatment Enalapril Women and Infants Hospital of Rhode Island

Reported

Estimated enrollment60

Primary outcome measure 1Feasibility of enrollment, 4 months

Primary outcome measure 2Feasibility of retention, 4 months